Researchers highlight gaps in disclosure of payments between radiologists and AI device manufacturers, urging greater transparency to ensure ethical AI deployment.
Key Details
- 1Many AI-enabled radiology devices have been FDA cleared in the past decade.
- 2Researchers found that over 90% of these device manufacturers reported zero payments to healthcare professionals or teaching hospitals (2017–2023).
- 3This is attributed to regulatory gaps and ambiguities in AI device classification and reporting requirements.
- 4Recent commenters on FDA AI regulations often failed to disclose industry ties.
Why It Matters
As AI becomes more integral to radiology, undisclosed relationships between clinicians and developers could bias research, product adoption, and regulatory processes. Strengthening transparency safeguards patient trust and ensures objective evaluation of new technologies.
Source
Radiology Business
Related News
•Radiology Business
Nvidia CEO Highlights AI’s Expanding Impact on Radiology Careers
Nvidia CEO Jensen Huang says AI is making radiologists more essential, not obsolete.
•Radiology Business
AI Tool Outperforms Radiologists in Pancreatic Cancer Detection
AI demonstrated superior accuracy over radiologists in detecting pancreatic cancer, according to new comparative data.
•AuntMinnie
AI Model Shows Promise for Detecting Meningiomas on Skull X-rays
South Korean researchers developed an AI model that detects meningiomas on skull x-rays, showing high accuracy in initial tests.